key: cord-0699599-mfaza5rg authors: Chen, Ruchong; Sang, Ling; Jiang, Mei; Yang, Zhaowei; Jia, Nan; Fu, Wanyi; Xie, Jiaxing; Guan, Weijie; Liang, Wenhua; Ni, Zhengyi; Hu, Yu; Liu, Lei; Shan, Hong; Lei, Chunliang; Peng, Yixiang; Wei, Li; Liu, Yong; Hu, Yahua; Peng, Peng; Wang, Jianming; Liu, Jiyang; Chen, Zhong; Li, Gang; Zheng, Zhijian; Qiu, Shaoqin; Luo, Jie; Ye, Changjiang; Zhu, Shaoyong; Zheng, Jinping; Zhang, Nuofu; Li, Yimin; He, Jianxing; Li, Jing; Li, Shiyue; Zhong, Nanshan title: Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China date: 2020-05-11 journal: J Allergy Clin Immunol DOI: 10.1016/j.jaci.2020.05.003 sha: 8b78c1ebc0c43c7540b149814ee97aa2fb3e7d04 doc_id: 699599 cord_uid: mfaza5rg Background Crucial roles of hematologic and immunologic responses in progression of COVID-19 remains largely unclear. Objective We sought to address the dynamic changes of hematologic and immunologic biomarkers and their associations with severity and outcomes of the disease. Methods A retrospective study including 548 COVID-19 patients with clarified outcome (discharged or deceased) from a national cohort in China was performed. Cross-sectional and longitudinal variations were compared and the associations with different severity and outcomes were analyzed. Results On admission, the counts of lymphocytes, T cell subsets, eosinophils and platelets decreased markedly, especially in severe/critical and fatal patients. Increased neutrophil count and neutrophils-to-lymphocytes ratio were predominant in severe/critical cases or non-survivors. During hospitalization, eosinophils, lymphocytes and platelets were shown an increasing trend in survivors, but maintained lower levels or dropped significantly afterwards in non-survivors. Non-survivors kept high level or showed an upward trend for neutrophils, IL-6, procalcitonin, D-dimer, amyloid A protein and C-reactive protein, which were kept stable or shown downward trend in survivors. Positive correlation between CD8+ T cell and lymphocytes count was found in survivors but not in non-survivors. A multivariate Cox regression model suggested that restored levels of lymphocytes, eosinophils and platelets could serve as the predictors for the recovery, while progressive increases in neutrophils, basophils and IL-6 were associated with fatal outcome. Conclusions Hematologic and immunologic impairment showed a significantly different profile between survivors and non-survivors in COVID-19 patients with different severity. The longitudinal variations of these biomarkers could serve to predict recovery or fatal outcome. On December 31, 2019, a cluster of pneumonia cases of unknown origins in Wuhan 142 linked to exposure to seafood-market was reported 1 . The causative agent was 143 determined to be a novel β-coronavirus, which is currently named as severe acute Continuous variables with normal distribution were described using mean ± standard 200 deviation (SD), otherwise, using median and interquartile range (IQR). Categorical 201 variables were described as number (percentage). We conducted t-test and 202 Mann-Whitney test to identify differences between survivors and non- Clinical features of patients 585 infected with 2019 novel coronavirus in Wuhan, China A Novel Coronavirus 588 from Patients with Pneumonia in China World Health Organization: Coronavirus disease 2019 (COVID-19) Situation 1-sitrep-92-covid-19.pdf?sfvrsn=38e6b06d_4. Released by World Health 593 Organization on Characterization of Ultrapotent Human 598 Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient Clinical Characteristics 601 of Coronavirus Disease 2019 in China Epidemiological and 604 clinical characteristics of 99 cases of China: a descriptive study Characteristics of and Important Lessons From the COVID-19) Outbreak in China: Summary of a Report 608 of 72314 Cases From the Chinese Center for Disease Control and Prevention Clinical course and risk factors 611 for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective 612 cohort study Pathological findings of 614 COVID-19 associated with acute respiratory distress syndrome Haematological 617 manifestations in patients with severe acute respiratory syndrome: retrospective 618 analysis Thrombocytopenia in patients with severe acute 701 respiratory syndrome (review) Multicenter Retrospective Cohort Study Thrombocytopenia is associated with severe 712 coronavirus disease 2019 (COVID-19) infections: A meta-analysis Predictors of MERS-CoV infection: A large case control study of patients 719 presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia Ultrastructural Findings of a Fatal 723 Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Longitudinal 726 characteristics of lymphocyte responses and cytokine profiles in the peripheral 727 blood of SARS-CoV-2 infected patients Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Human 740 immunopathogenesis of severe acute respiratory syndrome (SARS) Aberrant pathogenic 743 GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe 744 pulmonary syndrome patients of a new coronavirus Effective Treatment of Severe COVID-19 Patients with Tocilizumab Clinical 749 manifestations, laboratory findings, and treatment outcomes of SARS patients Hyperferritinemia and inflammation Structure and Expression of Different Serum Amyloid A (SAA) Variants and 755 their Concentration-Dependent Functions During Host Insults Protein chip array pneumonia 18) 15 (8, 21) a' 17 (11, 24) ‡ 9 CD4/CD8 70.93) 0.67 68.43 (59.97, 72.61) Data are presented as medians (IQR) and n/N (%). N is the total number of patients with available data SAA, serum amyloid A protein; CRP, C-reactive protein 01 Survivors compared with Non-survivors; a p<0.05, a' p<0.01 compared with Mild/Moderate; b p<0.05, b' p<0.01 compared with Severe. # Lymphocytes subsets by flow cytometry were detected in a total of 141 subjects (19 with fatal outcome), with different severity (94 mild/moderate cases P mg/L mg/L ng/mL mg/L pg/mL ng/mL